Horizon Investment Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,345
Closed -$231K 138
2025
Q2
$231K Buy
3,345
+15
+0.5% +$1.02K 0.1% 107
2025
Q1
$231K Sell
3,330
-369
-10% -$30.5K 0.11% 102
2024
Q4
$318K Buy
3,699
+764
+26% +$82.6K 0.14% 99
2024
Q3
$349K Hold
2,935
0.15% 90
2024
Q2
$419K Buy
2,935
+90
+3% +$11.9K 0.2% 80
2024
Q1
$365K Buy
2,845
+25
+0.9% +$2.98K 0.18% 82
2023
Q4
$292K Hold
2,820
0.16% 91
2023
Q3
$256K Hold
2,820
0.15% 90
2023
Q2
$228K Sell
2,820
-100
-3% -$8.17K 0.14% 98
2023
Q1
$232K Buy
+2,920
New +$207K 0.15% 101

Other funds holding NVO

Horizon Investment Services's NVO Position: Q3 2025 in Review

Horizon Investment Services sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 3,345 shares — an estimated $231K sold.

Horizon Investment Services first reported a position in NVO in Q1 2023 and held it in 10 quarters. The position peaked at $419K in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Horizon Investment Services reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Horizon Investment Services sold 3,345 Novo Nordisk shares in Q3 2025, an estimated $231K.
  • Horizon Investment Services first reported a position in Novo Nordisk in Q1 2023 and held it in 10 quarters.
  • Horizon Investment Services's Novo Nordisk position peaked at $419K in Q2 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Horizon Investment Services's 13F filing for Q3 2025, filed 5 Nov 2025.